Antidepressant-like effect of anacardic acid in mice via the L-arginine–nitric oxide–serotonergic system

Antonio Luiz Gomes Júnior, Jana Dimitrova Tchekalarova, Keylla da Conceição Machado, Samara Wanessa Cardoso Silva, Márcia Fernanda Correia Jardim Paz, Tiago Rocha Nogueira, Beatriz Santiago de Matos Monteiro Lira, S. M.Neamul Kabir Zihad, Muhammad Torequl Islam, Eunus S. Ali, Maria Alexsandra de Sousa Rios, André Luis Menezes Carvalho, Luciano da Silva Lopes, Swapan Kumar Saha, Mohammad S. Mubarak, Ana Amélia de Carvalho Melo-Cavalcante

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Depression, a multifactorial neuronal disorder with high morbidity/mortality, is associated with psychological, psychosocial, hereditary, and environmental etiologies, where reactive species exert pathophysiological functions. Anacardic acid (AA), a natural compound obtained from cashew nut liquid, has several pharmacological activities, including antioxidant and anticonvulsant. The aim of the present study was to evaluate the antidepressant-like effect of AA and the involvement of serotonergic, noradrenergic, and L-arginine–nitric oxide (NO) in tail suspension and forced swim tests and, more so, to investigate its antioxidant effect in Saccharomyces cerevisiae and in male Swiss mice (n = 8). In order to identify the antidepressant mechanisms, AA (10, 25, or 50 mg/kg, p.o.) was given 30 min before clonidine (2-adrenergic receptor agonist), L-arginine (NO precursor), propranolol (β-adrenergic receptor antagonist), and several other agonists or antagonists used. On the other hand, clonidine, noradrenoreceptor, noradrenaline, and L-arginine were used to identify the antidepressant mechanisms. Results suggest that AA exerts antidepressant-like activity, especially at higher doses, possibly by inhibiting serotonin and 5HT-1A reuptake receptors and by inhibiting NO synthetase and guanylyl cyclase enzymes. Additionally, AA exhibited antioxidant effect in S. cerevisiae. This antioxidant capacity may be linked to its antidepressant-like effect but does not interact with α- and β-adrenoceptor receptors. In conclusion, AA may be used as a promising agent to treat depression, especially which arises from oxidative stress.

Original languageEnglish
Pages (from-to)2126-2138
Number of pages13
JournalPhytotherapy Research
Volume33
Issue number8
DOIs
StatePublished - Aug 2019

Bibliographical note

Publisher Copyright:
© 2019 John Wiley & Sons, Ltd.

Funding

Authors acknowledge Prof. Dr. Rivelilson Mendes de Freitas (In memoriam) for his help and continuous guidance support during this study. We are also grateful to the Brazilian National Counsel of Technological and Scientific Development-CNPq (Grant Numbers 232683/2014-0 and 401476/2014-6) for funding. Authors acknowledge Prof. Dr. Rivelilson Mendes de Freitas (In memoriam) for his help and continuous guidance support during this study. We are also grateful to the Brazilian National Counsel of Technological and Scientific Development‐CNPq (Grant Numbers 232683/2014‐0 and 401476/2014‐6) for funding.

FundersFunder number
Brazilian National Counsel of Technological and Scientific Development-CNPq
Brazilian National Counsel of Technological and Scientific Development-CNPq232683/2014‐0, 401476/2014‐6

    Keywords

    • Saccharomyces cerevisiae
    • anacardic acid
    • behavioral animal models
    • depression
    • forced swim test

    ASJC Scopus subject areas

    • Pharmacology

    Fingerprint

    Dive into the research topics of 'Antidepressant-like effect of anacardic acid in mice via the L-arginine–nitric oxide–serotonergic system'. Together they form a unique fingerprint.

    Cite this